WO2001019383A1 - Stable carotene-xanthophyll beadlet compositions and methods of use - Google Patents
Stable carotene-xanthophyll beadlet compositions and methods of use Download PDFInfo
- Publication number
- WO2001019383A1 WO2001019383A1 PCT/US2000/024439 US0024439W WO0119383A1 WO 2001019383 A1 WO2001019383 A1 WO 2001019383A1 US 0024439 W US0024439 W US 0024439W WO 0119383 A1 WO0119383 A1 WO 0119383A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- carotene
- vitamin
- beadlets
- lutein
- zeaxanthin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Abstract
Description
Claims
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001523015A JP2003516720A (en) | 1999-09-17 | 2000-09-06 | Stable carotene-xanthophyll beadlet compositions and methods of use |
DE60032778T DE60032778T2 (en) | 1999-09-17 | 2000-09-06 | Compositions for stable carotene xanthophyll containing capsules and methods of use |
EP00959942A EP1212071B1 (en) | 1999-09-17 | 2000-09-06 | Stable carotene-xanthophyll beadlet compositions and methods of use |
BR0014087-2A BR0014087A (en) | 1999-09-17 | 2000-09-06 | Stable Carotene - Xanthophyll Pearl Compositions and Methods of Use |
MXPA02001837A MXPA02001837A (en) | 1999-09-17 | 2000-09-06 | Stable carotenexanthophyll beadlet compositions and methods of use. |
US10/088,188 US6716447B1 (en) | 1999-09-17 | 2000-09-06 | Stable carotene xanthophyll beadlet compositions and methods of use |
AU71172/00A AU780168B2 (en) | 1999-09-17 | 2000-09-06 | Stable carotene-xanthophyll beadlet compositions and methods of use |
CA002382008A CA2382008A1 (en) | 1999-09-17 | 2000-09-06 | Stable carotene-xanthophyll beadlet compositions and methods of use |
HK02107712.0A HK1048247B (en) | 1999-09-17 | 2002-10-24 | Stable carotene-xanthophyll beadlet compositions and methods of use |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/397,472 | 1999-09-17 | ||
US09/397,472 US6582721B1 (en) | 1999-09-17 | 1999-09-17 | Stable carotene-xanthophyll beadlet compositions and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001019383A1 true WO2001019383A1 (en) | 2001-03-22 |
Family
ID=23571337
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/024439 WO2001019383A1 (en) | 1999-09-17 | 2000-09-06 | Stable carotene-xanthophyll beadlet compositions and methods of use |
Country Status (13)
Country | Link |
---|---|
US (2) | US6582721B1 (en) |
EP (1) | EP1212071B1 (en) |
JP (1) | JP2003516720A (en) |
AR (1) | AR025247A1 (en) |
AT (1) | ATE350062T1 (en) |
AU (1) | AU780168B2 (en) |
BR (1) | BR0014087A (en) |
CA (1) | CA2382008A1 (en) |
DE (1) | DE60032778T2 (en) |
HK (1) | HK1048247B (en) |
MX (1) | MXPA02001837A (en) |
TW (1) | TWI232103B (en) |
WO (1) | WO2001019383A1 (en) |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002005827A2 (en) * | 2000-07-18 | 2002-01-24 | Forum Bioscience | Use of natural products in cancer treatment |
WO2002076242A1 (en) * | 2001-03-23 | 2002-10-03 | Bausch & Lomb Incorporated | Nutritional supplement to treat macular degeneration |
EP1249180A2 (en) * | 2001-03-26 | 2002-10-16 | Unilever N.V. | Structured particulate systems |
JP2003055188A (en) * | 2001-08-20 | 2003-02-26 | Fuji Chem Ind Co Ltd | Skin care preparation, cosmetic and food for preventing wrinkle formation |
JP2004035550A (en) * | 2002-05-07 | 2004-02-05 | Access Business Group Internatl Llc | Nutrition supplement of plant nutrient |
EP1437051A1 (en) | 2003-01-09 | 2004-07-14 | Dr. GERHARD MANN chem.-pharm. Fabrik GmbH | Ocuvite lutein |
EP1487418A1 (en) * | 2002-03-28 | 2004-12-22 | Alcon, Inc. | Co-beadlet of dha and rosemary and methods of use |
JP2005517694A (en) * | 2002-02-01 | 2005-06-16 | ケミン・フーズ・エル・シー | Microcapsules with high carotenoid content |
US6936279B2 (en) | 2002-06-18 | 2005-08-30 | Zeavision Llc | Microcrystalline zeaxanthin with high bioavailability in oily carrier formulations |
EP1635842A1 (en) * | 2003-06-20 | 2006-03-22 | Alcon, Inc. | Treatment of amd with combination of ingredients |
JP2006512390A (en) * | 2002-12-26 | 2006-04-13 | アディセオ・フランセ・エス・アー・エス | Uniform solid granules containing carotenoids |
EP1653935A1 (en) * | 2003-07-16 | 2006-05-10 | Natural Alternatives International, Inc. | Anti-inflammatory formulations |
US7267830B2 (en) * | 2003-12-19 | 2007-09-11 | Alcon, Inc. | Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision |
WO2008094825A2 (en) * | 2007-01-29 | 2008-08-07 | Bausch & Lomb Incorporated | Compositions and methods for maintaining, strengthening, improving or promoting eye health |
WO2009063333A2 (en) * | 2007-11-14 | 2009-05-22 | Omnica Gmbh | Compositions and methods to increase bioavailability of carotenoids |
EP2138055A1 (en) * | 2008-06-02 | 2009-12-30 | Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory | Formula food to be beneficial for visuognosis persistence and use thereof |
WO2011019875A2 (en) * | 2009-08-12 | 2011-02-17 | Melaleuca, Inc. | Antioxidant dietary supplement compositions |
CN101519396B (en) * | 2009-03-09 | 2011-10-26 | 浙江华源制药科技开发有限公司 | Method for purifying d-Alpha tocopherol succinate |
WO2012143492A1 (en) * | 2011-04-20 | 2012-10-26 | Dsm Ip Assets B.V. | Beadlets comprising carotenoids |
US9011911B2 (en) | 2002-04-23 | 2015-04-21 | Novartis Ag | High drug load tablet |
WO2015067706A1 (en) * | 2013-11-07 | 2015-05-14 | Dsm Ip Assets B.V. | Process for the purification of astaxanthin |
WO2015067711A1 (en) * | 2013-11-07 | 2015-05-14 | Dsm Ip Assets B.V. | Process for the purification of astaxanthin |
WO2015067707A1 (en) * | 2013-11-07 | 2015-05-14 | Dsm Ip Assets B.V. | Process for the purification of astaxanthin |
WO2015067703A1 (en) * | 2013-11-07 | 2015-05-14 | Dsm Ip Assets B.V. | Process for the purification of astaxanthin |
WO2015067705A1 (en) * | 2013-11-07 | 2015-05-14 | Dsm Ip Assets B.V. | Process for the purification of astaxanthin |
US9226515B2 (en) | 2004-02-03 | 2016-01-05 | Cargill, Incorporated | Protein concentrate and an aqueous stream containing water-soluble carbohydrates |
KR20170132176A (en) * | 2015-02-26 | 2017-12-01 | 스프링스카이 바이오메드 컴퍼니 리미티드 | Compound for treating ophthalmic diseases |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7239755B1 (en) * | 1997-07-30 | 2007-07-03 | Lg Electronics Inc. | Method of reducing a blocking artifact when coding moving picture |
US7115277B2 (en) * | 1999-03-04 | 2006-10-03 | Allergan, Inc. | Method for enabling delivery of an active agent |
US7438936B2 (en) * | 2000-06-12 | 2008-10-21 | Access Business Group International Llc | Dietary supplement and related method |
US7416749B2 (en) * | 2000-06-12 | 2008-08-26 | Access Business Group International Llc | Dietary supplement and related method |
US20030008048A1 (en) * | 2001-06-08 | 2003-01-09 | David Winston | Methods and compositions for helping the body resist the effects of the aging process |
US6811801B2 (en) * | 2001-12-12 | 2004-11-02 | Abbott Laboratories | Methods and compositions for brightening the color of thermally processed nutritionals |
AR039170A1 (en) * | 2002-03-28 | 2005-02-09 | Bio Dar Ltd | DHA AND ROMERO CO-GRANULES AND METHODS OF USE |
US8148431B2 (en) | 2002-10-25 | 2012-04-03 | Kemin Health, L.C. | Osteogenesis promoter containing β-cryptoxanthin as the active ingredient |
JP2005065525A (en) * | 2003-08-20 | 2005-03-17 | Koyo Shokai:Kk | Lutein- and blueberry-containing drink |
DE20320101U1 (en) * | 2003-12-23 | 2004-04-29 | Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh | Micronutrient combination product suitable for a supplementary balanced diet for age-related macular degeneration |
US9247765B2 (en) * | 2004-01-14 | 2016-02-02 | Omniactive Health Technologies Limited | Stable beadlets of lipophilic nutrients |
FR2869503B1 (en) * | 2004-04-29 | 2008-01-18 | Claude Bonne | FUNCTIONAL FOOD COMPOSITIONS FOR PREVENTING OR SLOWING THE EVOLUTION OF AGE-RELATED MACULAR DEGENERATION |
US20080070980A1 (en) * | 2004-05-18 | 2008-03-20 | Anne Eichinger | Use Of Beta-Cryptoxanthin |
DE202004010212U1 (en) * | 2004-06-30 | 2004-09-23 | Dr. Mann Pharma, Chem.-Pharm. Fabrik Gmbh | Lutein-containing composition |
JP2008506732A (en) * | 2004-07-21 | 2008-03-06 | ディーエスエム アイピー アセッツ ビー.ブイ. | Preparation of 4-ketorthein and use as food additive |
US20060134226A1 (en) * | 2004-11-16 | 2006-06-22 | Todd Leonard | Compositions useful to treat ocular neovascular diseases and macular degeneration |
US7981858B1 (en) | 2004-12-22 | 2011-07-19 | Alcon, Inc. | Methods of using zinc containing compounds to improve ocular health |
FR2883182B1 (en) * | 2005-03-16 | 2008-02-15 | Novartis Ag | VITAMIN COMPOSITION USEFUL IN THE TREATMENT OF OCULAR DISEASES |
US20070092578A1 (en) * | 2005-10-26 | 2007-04-26 | Yasuhiro Itagaki | Skin rejuvinating supplement |
US20070207116A1 (en) * | 2006-03-01 | 2007-09-06 | Brown David C | Antioxidant compositions for the eye |
US8278358B2 (en) * | 2006-07-06 | 2012-10-02 | Omnica Gmbh | Lipoic acid derivatives |
US7282225B1 (en) * | 2006-09-27 | 2007-10-16 | Occular Technologies, Inc. | Composition and methods for improving retinal health |
JP5376486B2 (en) * | 2007-01-30 | 2013-12-25 | 学校法人東京農業大学 | Method for producing lutein-containing yellow pigment derived from cricula koji |
JP5702514B2 (en) * | 2007-10-26 | 2015-04-15 | 丸善製薬株式会社 | Stabilization method for photodegradation of lutein |
JP2009107945A (en) * | 2007-10-26 | 2009-05-21 | Maruzen Pharmaceut Co Ltd | Inhibitor of optic nerve disorder and food and drink containing the same |
US20090118228A1 (en) * | 2007-11-07 | 2009-05-07 | Bristol-Myers Squibb Company | Carotenoid-containing compositions and methods |
JP2010105984A (en) * | 2008-10-31 | 2010-05-13 | Unitika Ltd | Oral administration composition |
US20100159029A1 (en) * | 2008-12-23 | 2010-06-24 | Alcon Research, Ltd. | Composition and nutritional supplements for improving ocular health and reducing ocular inflammatory response |
US20130295171A1 (en) | 2009-07-23 | 2013-11-07 | U.S NUTRACEUTICALS, LLC d/b/a Valensa International | Krill oil and reacted astaxanthin composition and associated method |
US20110237548A1 (en) * | 2009-07-23 | 2011-09-29 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Synergistic composition and method of retarding and ameliorating photo induced retinal damage and cataracts while ameliorating dry eye syndrome using omega choline |
US20130011469A1 (en) | 2009-07-23 | 2013-01-10 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Krill oil and carotenoid composition, associated method and delivery system |
US20110021465A1 (en) * | 2009-07-23 | 2011-01-27 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Synergistic composition and method of retarding and ameliorating photo induced retinal damage and cataracts while ameliorating dry eye syndrome |
WO2011057183A1 (en) | 2009-11-06 | 2011-05-12 | Alcon Research, Ltd. | Nutritional supplements for relief of dry eye |
EP2542096B1 (en) * | 2010-03-05 | 2015-07-15 | Ophthalmopharma AG | Nutraceutical chocolate or compound chocolate product |
JP6026719B2 (en) * | 2010-08-31 | 2016-11-16 | 株式会社ダイセル | Visual function preventive / improving agent |
WO2013043366A1 (en) * | 2011-09-20 | 2013-03-28 | Nestec S.A. | Methods and compositions for improving visual function and eye health |
JP5565780B2 (en) * | 2012-09-28 | 2014-08-06 | 学校法人東京農業大学 | Krycula 繭 pigment and its use |
WO2015067709A1 (en) * | 2013-11-07 | 2015-05-14 | Dsm Ip Assets B.V. | Process for the purification of astaxanthin |
WO2015173603A1 (en) | 2014-05-16 | 2015-11-19 | Omniactive Health Technologies Limited | Hydrophilic matrix beadlet compositions with enhanced bioavailability |
JP6370612B2 (en) * | 2014-06-05 | 2018-08-08 | 株式会社ファンケル | Dihydroquercetin and astaxanthin-containing composition |
JP6267066B2 (en) * | 2014-06-20 | 2018-01-24 | 株式会社ファンケル | Controlled release soft capsule |
WO2016007720A1 (en) * | 2014-07-10 | 2016-01-14 | Fmc Corporation | Improved pigment formulation |
JP6978103B2 (en) * | 2015-07-01 | 2021-12-08 | 株式会社東洋新薬 | Retinal protection composition |
JP2017025171A (en) * | 2015-07-17 | 2017-02-02 | 三栄源エフ・エフ・アイ株式会社 | Tablet-shaped edible composition |
CA3032229A1 (en) | 2016-07-27 | 2018-02-01 | Hartis-Pharma Sa | Therapeutic combinations to treat red blood cell disorders |
KR102422516B1 (en) * | 2017-12-08 | 2022-07-19 | 첸광 바이오테크 그룹 캄파니 리미티드 | Lycopene microcapsule powder and its manufacturing method |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998011789A1 (en) * | 1996-09-20 | 1998-03-26 | The Howard Foundation | Flavonol containing food supplements |
WO1998033494A1 (en) * | 1997-02-04 | 1998-08-06 | Kosbab John V | Compositions and methods for prevention and treatment of vascular degenerative diseases |
US5895652A (en) * | 1996-07-29 | 1999-04-20 | Longevity Institute International | Method of metabolic adjuvanation and cellular repair |
US5955102A (en) * | 1998-09-04 | 1999-09-21 | Amway Corporation | Softgel capsule containing DHA and antioxidants |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2917539A (en) | 1955-12-29 | 1959-12-15 | Hoffmann La Roche | Process for the manufacture of carotenoids |
US3998753A (en) | 1974-08-13 | 1976-12-21 | Hoffmann-La Roche Inc. | Water dispersible carotenoid preparations and processes thereof |
CH627449A5 (en) | 1977-03-25 | 1982-01-15 | Hoffmann La Roche | METHOD FOR PRODUCING MICROCRYSTALLINE VITAMIN A-ACETATE, AND DRY, FREE-FLOWING PREPAIRS IN WHICH VITAMIN A-ACETATE IS IN A MICROCRYSTALLINE FORM. |
DE3119383A1 (en) | 1981-05-15 | 1982-12-02 | Basf Ag, 6700 Ludwigshafen | METHOD FOR PRODUCING FINE DISTRIBUTED, POWDERED CAROTINO PREPARATIONS |
US4670247A (en) | 1983-07-05 | 1987-06-02 | Hoffman-Laroche Inc. | Process for preparing fat-soluble vitamin active beadlets |
DE3611229A1 (en) | 1986-04-04 | 1987-10-08 | Basf Ag | METHOD FOR PRODUCING FINE DISTRIBUTED, POWDERED CAROTINOID PREPARATIONS |
DE59003205D1 (en) | 1989-07-25 | 1993-12-02 | Hoffmann La Roche | Process for the preparation of carotenoid preparations. |
ES2104608T3 (en) | 1989-08-30 | 1997-10-16 | Applied Food Biotech Inc | PROCEDURE FOR THE PRODUCTION OF A COMPOSITION CONTAINING ZEAXANTIN USING A MICROORGANISM OF THE SPECIES FLAVOBACTERIUM MULTIVORUM. |
DK546289D0 (en) | 1989-11-02 | 1989-11-02 | Danochemo As | carotenoid |
AU660630B2 (en) | 1990-10-01 | 1995-07-06 | Brigham And Women's Hospital | Beta-carotene and vitamin E therapy for inhibition of major vascular events |
DE4141351A1 (en) | 1991-12-14 | 1993-06-17 | Basf Ag | STABLE POWDERFUL VITAMIN AND / OR CAROTINOIDE PREPARATES AND PROCESS FOR THEIR PREPARATION |
DE4200728A1 (en) | 1992-01-14 | 1993-07-15 | Basf Ag | STABLE, LIQUID PREPARATIONS OF FAT-SOLUBLE SUBSTANCES |
DE59306812D1 (en) | 1992-04-14 | 1997-07-31 | Hoffmann La Roche | Preparations of fat-soluble substances |
GB9219524D0 (en) | 1992-09-15 | 1992-10-28 | Smithkline Beecham Plc | Novel composition |
FR2703263B1 (en) | 1993-03-31 | 1995-05-19 | Rhone Poulenc Nutrition Animal | Process for the preparation of spherules of active principles. |
US5466599A (en) | 1993-04-19 | 1995-11-14 | Universal Foods Corporation | Astaxanthin over-producing strains of phaffia rhodozyma |
FR2707184B1 (en) | 1993-07-08 | 1995-08-11 | Rhone Poulenc Nutrition Animal | Process for the preparation of spherules containing an active food or pharmaceutical ingredient. |
US5382714A (en) | 1994-03-17 | 1995-01-17 | The Catholic University Of America | Process for isolation, purification, and recrystallization of lutein from saponified marigold oleoresin and uses thereof |
US5527533A (en) | 1994-10-27 | 1996-06-18 | Board Of Trustees Of The University Of Illinois | Method of retarding and ameliorating central nervous system and eye damage |
AU702831B2 (en) * | 1994-12-22 | 1999-03-04 | Henkel Corporation | Compositions of tocopherol and beta-carotene |
US5596011A (en) * | 1995-04-06 | 1997-01-21 | Repine; Karen M. | Method for the treatment of macular degeneration |
US5747544A (en) | 1995-10-31 | 1998-05-05 | Applied Food Biotechnology, Inc. | Method of using pure 3R-3'R stereoisomer of zeaxanthin to treat or prevent retinal degeneration in humans |
US5648564A (en) | 1995-12-21 | 1997-07-15 | Kemin Industries, Inc. | Process for the formation, isolation and purification of comestible xanthophyll crystals from plants |
DE19609477A1 (en) | 1996-03-11 | 1997-09-18 | Basf Ag | Stable aqueous solubilisates of carotenoids and vitamins |
-
1999
- 1999-09-17 US US09/397,472 patent/US6582721B1/en not_active Expired - Fee Related
-
2000
- 2000-08-08 TW TW089115937A patent/TWI232103B/en active
- 2000-08-15 AR ARP000104213A patent/AR025247A1/en unknown
- 2000-09-06 WO PCT/US2000/024439 patent/WO2001019383A1/en active IP Right Grant
- 2000-09-06 MX MXPA02001837A patent/MXPA02001837A/en active IP Right Grant
- 2000-09-06 JP JP2001523015A patent/JP2003516720A/en active Pending
- 2000-09-06 AU AU71172/00A patent/AU780168B2/en not_active Ceased
- 2000-09-06 US US10/088,188 patent/US6716447B1/en not_active Expired - Fee Related
- 2000-09-06 BR BR0014087-2A patent/BR0014087A/en not_active Application Discontinuation
- 2000-09-06 DE DE60032778T patent/DE60032778T2/en not_active Revoked
- 2000-09-06 AT AT00959942T patent/ATE350062T1/en not_active IP Right Cessation
- 2000-09-06 EP EP00959942A patent/EP1212071B1/en not_active Revoked
- 2000-09-06 CA CA002382008A patent/CA2382008A1/en not_active Abandoned
-
2002
- 2002-10-24 HK HK02107712.0A patent/HK1048247B/en not_active IP Right Cessation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5895652A (en) * | 1996-07-29 | 1999-04-20 | Longevity Institute International | Method of metabolic adjuvanation and cellular repair |
WO1998011789A1 (en) * | 1996-09-20 | 1998-03-26 | The Howard Foundation | Flavonol containing food supplements |
WO1998033494A1 (en) * | 1997-02-04 | 1998-08-06 | Kosbab John V | Compositions and methods for prevention and treatment of vascular degenerative diseases |
US5955102A (en) * | 1998-09-04 | 1999-09-21 | Amway Corporation | Softgel capsule containing DHA and antioxidants |
Cited By (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002005827A2 (en) * | 2000-07-18 | 2002-01-24 | Forum Bioscience | Use of natural products in cancer treatment |
WO2002005827A3 (en) * | 2000-07-18 | 2002-07-18 | Forum Bioscience | Use of natural products in cancer treatment |
EP1516542A1 (en) * | 2001-03-23 | 2005-03-23 | Bausch & Lomb Incorporated | Nutritional supplement to treat macular degeneration |
WO2002076242A1 (en) * | 2001-03-23 | 2002-10-03 | Bausch & Lomb Incorporated | Nutritional supplement to treat macular degeneration |
EP1447012A1 (en) * | 2001-03-23 | 2004-08-18 | Bausch & Lomb Incorporated | Nutritional supplement to treat macular degeneration |
US8603522B2 (en) | 2001-03-23 | 2013-12-10 | Bausch & Lomb Incorporated | Nutritional supplement to treat macular degeneration |
US6660297B2 (en) | 2001-03-23 | 2003-12-09 | Bausch & Lomb Incorporated | Nutritional supplement to treat macular degeneration |
US6773733B2 (en) | 2001-03-26 | 2004-08-10 | Loders Croklaan Usa Llc | Structured particulate systems |
EP1249180A3 (en) * | 2001-03-26 | 2003-09-03 | Loders Croklaan B.V. | Structured particulate systems |
EP1249180A2 (en) * | 2001-03-26 | 2002-10-16 | Unilever N.V. | Structured particulate systems |
JP2003055188A (en) * | 2001-08-20 | 2003-02-26 | Fuji Chem Ind Co Ltd | Skin care preparation, cosmetic and food for preventing wrinkle formation |
JP2005517694A (en) * | 2002-02-01 | 2005-06-16 | ケミン・フーズ・エル・シー | Microcapsules with high carotenoid content |
JP2012006943A (en) * | 2002-02-01 | 2012-01-12 | Kemin Foods Lc | Microcapsules having high carotenoid content |
EP1487418A1 (en) * | 2002-03-28 | 2004-12-22 | Alcon, Inc. | Co-beadlet of dha and rosemary and methods of use |
AU2003220417B2 (en) * | 2002-03-28 | 2009-03-12 | Alcon, Inc. | Co-beadlet of DHA and rosemary and methods of use |
EP1487418A4 (en) * | 2002-03-28 | 2005-07-13 | Alcon Inc | Co-beadlet of dha and rosemary and methods of use |
US9011911B2 (en) | 2002-04-23 | 2015-04-21 | Novartis Ag | High drug load tablet |
JP2004035550A (en) * | 2002-05-07 | 2004-02-05 | Access Business Group Internatl Llc | Nutrition supplement of plant nutrient |
JP2008273979A (en) * | 2002-05-07 | 2008-11-13 | Access Business Group Internatl Llc | Nutrition supplement comprising plant nutrient |
US6936279B2 (en) | 2002-06-18 | 2005-08-30 | Zeavision Llc | Microcrystalline zeaxanthin with high bioavailability in oily carrier formulations |
JP2006512390A (en) * | 2002-12-26 | 2006-04-13 | アディセオ・フランセ・エス・アー・エス | Uniform solid granules containing carotenoids |
EP1437051A1 (en) | 2003-01-09 | 2004-07-14 | Dr. GERHARD MANN chem.-pharm. Fabrik GmbH | Ocuvite lutein |
EP1635842A4 (en) * | 2003-06-20 | 2007-04-04 | Alcon Inc | Treatment of amd with combination of ingredients |
JP2007521274A (en) * | 2003-06-20 | 2007-08-02 | アルコン,インコーポレイテッド | Treatment of age-related macular degeneration using a combination of multiple components |
EP1635842A1 (en) * | 2003-06-20 | 2006-03-22 | Alcon, Inc. | Treatment of amd with combination of ingredients |
EP1653935A1 (en) * | 2003-07-16 | 2006-05-10 | Natural Alternatives International, Inc. | Anti-inflammatory formulations |
AU2004259223B2 (en) * | 2003-07-16 | 2011-04-07 | David Haines | Anti-inflammatory formulations |
EP1653935A4 (en) * | 2003-07-16 | 2009-05-27 | Natural Alternatives Internati | Anti-inflammatory formulations |
US7267830B2 (en) * | 2003-12-19 | 2007-09-11 | Alcon, Inc. | Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision |
US9226515B2 (en) | 2004-02-03 | 2016-01-05 | Cargill, Incorporated | Protein concentrate and an aqueous stream containing water-soluble carbohydrates |
US10154679B2 (en) | 2004-02-03 | 2018-12-18 | Cargill, Incorporated | Protein concentrate and an aqueous stream containing water-soluble carbohydrates |
WO2008094825A3 (en) * | 2007-01-29 | 2008-10-02 | Bausch & Lomb | Compositions and methods for maintaining, strengthening, improving or promoting eye health |
WO2008094825A2 (en) * | 2007-01-29 | 2008-08-07 | Bausch & Lomb Incorporated | Compositions and methods for maintaining, strengthening, improving or promoting eye health |
WO2009063333A2 (en) * | 2007-11-14 | 2009-05-22 | Omnica Gmbh | Compositions and methods to increase bioavailability of carotenoids |
WO2009063333A3 (en) * | 2007-11-14 | 2009-09-24 | Omnica Gmbh | Compositions and methods to increase bioavailability of carotenoids |
EP2138055A1 (en) * | 2008-06-02 | 2009-12-30 | Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory | Formula food to be beneficial for visuognosis persistence and use thereof |
CN101519396B (en) * | 2009-03-09 | 2011-10-26 | 浙江华源制药科技开发有限公司 | Method for purifying d-Alpha tocopherol succinate |
WO2011019875A3 (en) * | 2009-08-12 | 2011-06-09 | Melaleuca, Inc. | Antioxidant dietary supplement compositions |
US8491939B2 (en) | 2009-08-12 | 2013-07-23 | Melaleuca, Inc. | Antioxidant dietary supplement compositions |
US20110038967A1 (en) * | 2009-08-12 | 2011-02-17 | Melaleuca, Inc. | Antioxidant dietary supplement compositions |
WO2011019875A2 (en) * | 2009-08-12 | 2011-02-17 | Melaleuca, Inc. | Antioxidant dietary supplement compositions |
WO2012143492A1 (en) * | 2011-04-20 | 2012-10-26 | Dsm Ip Assets B.V. | Beadlets comprising carotenoids |
WO2015067707A1 (en) * | 2013-11-07 | 2015-05-14 | Dsm Ip Assets B.V. | Process for the purification of astaxanthin |
WO2015067703A1 (en) * | 2013-11-07 | 2015-05-14 | Dsm Ip Assets B.V. | Process for the purification of astaxanthin |
WO2015067705A1 (en) * | 2013-11-07 | 2015-05-14 | Dsm Ip Assets B.V. | Process for the purification of astaxanthin |
WO2015067711A1 (en) * | 2013-11-07 | 2015-05-14 | Dsm Ip Assets B.V. | Process for the purification of astaxanthin |
CN105705042A (en) * | 2013-11-07 | 2016-06-22 | 帝斯曼知识产权资产管理有限公司 | Process for the purification of astaxanthin |
CN105705040A (en) * | 2013-11-07 | 2016-06-22 | 帝斯曼知识产权资产管理有限公司 | Process for the purification of astaxanthin |
WO2015067706A1 (en) * | 2013-11-07 | 2015-05-14 | Dsm Ip Assets B.V. | Process for the purification of astaxanthin |
EP3514143A1 (en) * | 2013-11-07 | 2019-07-24 | DSM IP Assets B.V. | Dietary supplements, oily suspensions and powdery formulations comprising synthetic food-grade astaxanthin |
KR20170132176A (en) * | 2015-02-26 | 2017-12-01 | 스프링스카이 바이오메드 컴퍼니 리미티드 | Compound for treating ophthalmic diseases |
EP3261635A4 (en) * | 2015-02-26 | 2018-11-14 | NatureWise Biotech & Medicals Corporation | Compounds for treating ocular diseases |
KR102082351B1 (en) | 2015-02-26 | 2020-02-27 | 스프링스카이 바이오메드 컴퍼니 리미티드 | Compounds for Treating Eye Diseases |
Also Published As
Publication number | Publication date |
---|---|
AR025247A1 (en) | 2002-11-13 |
TWI232103B (en) | 2005-05-11 |
DE60032778D1 (en) | 2007-02-15 |
ATE350062T1 (en) | 2007-01-15 |
MXPA02001837A (en) | 2002-08-12 |
HK1048247A1 (en) | 2003-03-28 |
CA2382008A1 (en) | 2001-03-22 |
DE60032778T2 (en) | 2007-11-08 |
HK1048247B (en) | 2007-06-29 |
US6716447B1 (en) | 2004-04-06 |
BR0014087A (en) | 2003-07-29 |
EP1212071A1 (en) | 2002-06-12 |
EP1212071B1 (en) | 2007-01-03 |
AU780168B2 (en) | 2005-03-03 |
US6582721B1 (en) | 2003-06-24 |
JP2003516720A (en) | 2003-05-20 |
AU7117200A (en) | 2001-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU780168B2 (en) | Stable carotene-xanthophyll beadlet compositions and methods of use | |
US7842722B2 (en) | Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision | |
US20070141170A1 (en) | Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision | |
EP1516542B1 (en) | Nutritional supplement to treat macular degeneration | |
US20100159029A1 (en) | Composition and nutritional supplements for improving ocular health and reducing ocular inflammatory response | |
AU719671B2 (en) | Pharmaceutically active carotenoids | |
US6218436B1 (en) | Pharmaceutically active carotenoids | |
US20050249821A1 (en) | Nutritional supplement for treatment of ocular diseases | |
US20110111055A1 (en) | Nutritional supplements for relief of dry eye | |
US7981858B1 (en) | Methods of using zinc containing compounds to improve ocular health | |
MX2008007883A (en) | Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision | |
AU2005239703B2 (en) | Nutritional supplement to treat macular degeneration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU BR CA JP MX TR US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2382008 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 71172/00 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2002/001837 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000959942 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10088188 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2001 523015 Kind code of ref document: A Format of ref document f/p: F |
|
WWP | Wipo information: published in national office |
Ref document number: 2000959942 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 71172/00 Country of ref document: AU |
|
WWG | Wipo information: grant in national office |
Ref document number: 2000959942 Country of ref document: EP |